Randomized Trial: Mycophenolate Mofetil vs. Cyclophosphamide for Remission Induction in ANCA-associated Vasculitis
10 Feb, 2019 | 13:46h | UTCMycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial – Annals of Rheumatic Diseases (link to abstract – $ for full-text)
Commentary: Randomized data back EULAR guidelines for mycophenolate mofetil use in AAV – Medwire News (free)